33 related articles for article (PubMed ID: 10023677)
1. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter.
Song H; Kim JH; Rho JK; Park SY; Kim CG; Choe SY
Mol Cells; 1999 Oct; 9(5):560-3. PubMed ID: 10597047
[TBL] [Abstract][Full Text] [Related]
2. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.
Teppo S; Laukkanen S; Liuksiala T; Nordlund J; Oittinen M; Teittinen K; Grönroos T; St-Onge P; Sinnett D; Syvänen AC; Nykter M; Viiri K; Heinäniemi M; Lohi O
Genome Res; 2016 Nov; 26(11):1468-1477. PubMed ID: 27620872
[TBL] [Abstract][Full Text] [Related]
4. DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association.
Green SM; Coyne HJ; McIntosh LP; Graves BJ
J Biol Chem; 2010 Jun; 285(24):18496-504. PubMed ID: 20400516
[TBL] [Abstract][Full Text] [Related]
5. CBFbeta is critical for AML1-ETO and TEL-AML1 activity.
Roudaia L; Cheney MD; Manuylova E; Chen W; Morrow M; Park S; Lee CT; Kaur P; Williams O; Bushweller JH; Speck NA
Blood; 2009 Mar; 113(13):3070-9. PubMed ID: 19179469
[TBL] [Abstract][Full Text] [Related]
6. Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.
Alarcón-Riquelme ME
Arthritis Res Ther; 2004; 6(4):169-73. PubMed ID: 15225361
[TBL] [Abstract][Full Text] [Related]
7. Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression.
Kim CA; Phillips ML; Kim W; Gingery M; Tran HH; Robinson MA; Faham S; Bowie JU
EMBO J; 2001 Aug; 20(15):4173-82. PubMed ID: 11483520
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of leukemia.
Jakubowiak A; Cammenga J; Sokolic R; Alvarez S; Jackson G; Hedvat C; Nimer SD
Curr Oncol Rep; 2000 Mar; 2(2):123-31. PubMed ID: 11122833
[TBL] [Abstract][Full Text] [Related]
9. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.
Fenrick R; Amann JM; Lutterbach B; Wang L; Westendorf JJ; Downing JR; Hiebert SW
Mol Cell Biol; 1999 Oct; 19(10):6566-74. PubMed ID: 10490596
[TBL] [Abstract][Full Text] [Related]
10. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
Zuna J
Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199
[TBL] [Abstract][Full Text] [Related]
11. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.
Zelent A; Greaves M; Enver T
Oncogene; 2004 May; 23(24):4275-83. PubMed ID: 15156184
[TBL] [Abstract][Full Text] [Related]
12. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.
Uchida H; Downing JR; Miyazaki Y; Frank R; Zhang J; Nimer SD
Oncogene; 1999 Jan; 18(4):1015-22. PubMed ID: 10023677
[TBL] [Abstract][Full Text] [Related]
13. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
[TBL] [Abstract][Full Text] [Related]
14. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
[TBL] [Abstract][Full Text] [Related]
15. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
